Stock SBRA SABRA HEALTH CARE REIT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sabra Health Care REIT, Inc.

Equities

SBRA

US78573L1061

Specialized REITs

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
13.94 USD +2.12% Intraday chart for Sabra Health Care REIT, Inc. +2.05% -2.31%
Feb. 28 Transcript : Sabra Health Care REIT, Inc., Q4 2023 Earnings Call, Feb 28, 2024
Feb. 28 Sabra Health Care REIT Q4 Adjusted FFO, Revenue Decline; Issues 2024 Guidance MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 4,317 3,594 3,096 2,871 3,300 3,227 - -
Enterprise Value (EV) 1 6,680 5,908 5,379 5,329 3,300 5,768 5,750 5,810
P/E ratio 57.7 x 25.9 x -26 x -36.6 x 238 x 24 x 21.6 x 20.2 x
Yield 8.43% 7.77% 8.86% 9.65% - 8.61% 8.9% 9.28%
Capitalization / Revenue 6.52 x 6 x 5.44 x 4.6 x 5.1 x 4.87 x 4.65 x 4.54 x
EV / Revenue 10.1 x 9.87 x 9.44 x 8.53 x 5.1 x 8.71 x 8.29 x 8.18 x
EV / EBITDA 12.8 x 13.6 x 14.3 x 12.6 x 8.15 x 13.5 x 12.8 x 12.8 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 1.26 x - 0.92 x 0.94 x - 1.1 x 1.08 x 1.07 x
Nbr of stocks (in thousands) 202,317 206,928 228,678 230,977 231,220 231,496 - -
Reference price 2 21.34 17.37 13.54 12.43 14.27 13.94 13.94 13.94
Announcement Date 2/24/20 2/22/21 2/22/22 2/21/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 661.7 598.6 569.5 624.8 647.5 662.1 693.3 710.4
EBITDA 1 522.8 434.3 376.4 422.6 404.6 428.4 448.7 452.6
EBIT 1 217.8 251.7 197.4 197.3 221.5 333 335.8 284
Operating Margin 32.91% 42.04% 34.65% 31.58% 34.21% 50.3% 48.44% 39.98%
Earnings before Tax (EBT) 1 72.42 139.1 -111.4 -76.36 15.76 134.9 152.6 159.1
Net income 1 69 138.4 -113.3 -77.6 13.76 134.8 151.4 163.1
Net margin 10.43% 23.12% -19.89% -12.42% 2.12% 20.37% 21.83% 22.95%
EPS 2 0.3700 0.6700 -0.5200 -0.3400 0.0600 0.5798 0.6458 0.6911
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 1.800 1.350 1.200 1.200 - 1.200 1.240 1.294
Announcement Date 2/24/20 2/22/21 2/22/22 2/21/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 128.6 135.7 163.1 156 140.8 165 161.3 161.2 161.6 163.4 162.4 164.4 166.6 168.6 170.3
EBITDA 1 84.07 82.1 103.6 108.7 89.48 110.3 103 102.9 101.7 97.2 105 106.7 107.5 108.3 110.8
EBIT 1 39.05 37.02 58.35 63.53 42.05 51.44 41.46 50.29 58.47 54.32 79.9 82.82 84.46 85.84 64.44
Operating Margin 30.37% 27.29% 35.77% 40.73% 29.87% 31.18% 25.7% 31.21% 36.18% 33.25% 49.2% 50.39% 50.68% 50.91% 37.83%
Earnings before Tax (EBT) 1 14.33 - 40.89 17.06 -49.48 -84.82 -8.759 22.17 -14.65 17.65 32.07 34.19 34.3 34.35 34.01
Net income 1 10.22 -24.35 40.6 16.8 -50.06 -84.95 -9.487 21.19 -15.1 17.16 31.9 33.99 34.38 34.56 36.05
Net margin 7.95% -17.95% 24.89% 10.78% -35.57% -51.49% -5.88% 13.15% -9.34% 10.5% 19.64% 20.68% 20.63% 20.5% 21.16%
EPS 2 0.0500 -0.1100 0.1800 0.0700 -0.2200 -0.3700 -0.0400 0.0900 -0.0700 0.0700 0.1386 0.1441 0.1475 0.1521 0.1542
Dividend per Share 2 0.3000 0.3000 0.3000 0.3000 0.3000 0.3000 0.3000 0.3000 0.3000 - 0.3000 0.3000 0.3000 0.3000 0.3138
Announcement Date 11/3/21 2/22/22 5/4/22 8/3/22 11/7/22 2/21/23 5/3/23 8/7/23 11/6/23 2/27/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,363 2,313 2,282 2,457 - 2,541 2,523 2,583
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 4.52 x 5.327 x 6.065 x 5.815 x - 5.931 x 5.623 x 5.707 x
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 2.05% 4.01% 2.55% 0.9% - 5.08% 5.81% 6.73%
ROA (Net income/ Total Assets) 1.08% - - - - 2.54% 2.84% 3.03%
Assets 1 6,367 - - - - 5,316 5,330 5,377
Book Value Per Share 2 17.00 - 14.70 13.20 - 12.70 12.90 13.00
Cash Flow per Share 2 - - 1.630 1.370 - 1.420 1.510 1.580
Capex 1 25.5 - - - - 50 - -
Capex / Sales 3.85% - - - - 7.55% - -
Announcement Date 2/24/20 2/22/21 2/22/22 2/21/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Sabra Health Care REIT, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
13.94 USD
Average target price
15.91 USD
Spread / Average Target
+14.13%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Healthcare REITs

1st Jan change Capi.
SABRA HEALTH CARE REIT, INC. Stock Sabra Health Care REIT, Inc.
-2.31% 3.23B
WELLTOWER INC. Stock Welltower Inc.
+4.62% 55.76B
VENTAS, INC. Stock Ventas, Inc.
-11.72% 17.72B
HEALTHPEAK PROPERTIES, INC. Stock Healthpeak Properties, Inc.
-5.05% 13.23B
OMEGA HEALTHCARE INVESTORS, INC. Stock Omega Healthcare Investors, Inc.
+1.40% 7.68B
HEALTHCARE REALTY TRUST INCORPORATED Stock Healthcare Realty Trust Incorporated
-16.54% 5.39B
CARETRUST REIT, INC. Stock CareTrust REIT, Inc.
+8.62% 3.28B
AEDIFICA SA Stock Aedifica SA
-5.42% 3.06B
MEDICAL PROPERTIES TRUST, INC. Stock Medical Properties Trust, Inc.
-8.15% 2.73B
NATIONAL HEALTH INVESTORS, INC. Stock National Health Investors, Inc.
+12.61% 2.73B
Healthcare REITs
  1. Stock Market
  2. Equities
  3. SBRA Stock
  4. Financials Sabra Health Care REIT, Inc.